---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-014345"
form_type: "8-K"
ticker: "RDGL"
cik: "0001449349"
company_name: "VIVOS INC"
filed_at: "2025-09-22T23:59:59+00:00"
generated_at: "2026-05-17T05:57:54.311642+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vivos appoints Brad Allan Weeks as President and David J. Swanberg as COO

## Summary
- Brad Allan Weeks appointed President effective Sept 1, 2025, with base salary $192,000/yr plus monthly stock grants.
- David J. Swanberg appointed COO via consulting agreement at $12,000/month plus stock grants.
- Weeks previously served as Business Development Manager; Swanberg has 35+ years in radiochemical processing and was co-founder of IsoRay.
- President term ends Dec 31, 2027; COO term ends Dec 31, 2028; both agreements include confidentiality and non-compete clauses.

## SEC filing metadata
- accession: 0001493152-25-014345
- form_type: 8-K
- ticker: RDGL
- cik: 0001449349
- company_name: VIVOS INC
- filed_at: 2025-09-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1449349/000149315225014345/0001493152-25-014345-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1449349/000149315225014345/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-014345
- JSON: https://secwatch.observer/filing/0001493152-25-014345.json
- Plain text: https://secwatch.observer/filing/0001493152-25-014345.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.